2021 annual financial data
Puma Biotechnology 2021 Net margin
Puma Biotechnology 2021 net margin with verified reported values.
Direct answer
Net margin was -11.51%.
Operating income was 1,290,000 USD and net income was -29,126,000 USD.
Operating cash flow was 20,650,000 USD.
Get free Puma Biotechnology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 253,155,000 USD
- Operating income
- 1,290,000 USD
- Net income
- -29,126,000 USD
- Operating cash flow
- 20,650,000 USD